electroCore to Participate in Upcoming Investor Conferences
Rhea-AI Summary
electroCore, a bioelectronic medicine and wellness company, has announced its participation in three upcoming investor events:
- October 1: One-on-one meetings at the Lytham Partners Virtual Fall Investor Conference
- October 17: Fireside chat with Anthony Vendetti at the Maxim Virtual Healthcare Summit
- October 29: One-on-one meetings and group presentation at the LD Micro Main Event XVII in Los Angeles
The LD Micro event presentation is scheduled for 4:30 p.m. PT. Live webcasts and replays will be available on electroCore's investor relations website. Investors can contact FNK IR to schedule meetings with management. The company's participation is subject to change.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, ECOR declined 1.99%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
ROCKAWAY, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following investor events:
- October 1 - Management will participate in one-on-one meetings at the Lytham Partners Virtual Fall Investor Conference
- October 17 -- Management will participate in a fireside chat with Anthony Vendetti, the Director of Research and Senior Healthcare Analyst, at the Maxim Virtual Healthcare Summit
- October 29 - Management will participate in one-on-one meetings, and host a group presentation at the LD Micro Main Event XVII. This event will take place in Los Angeles, California and the company’s group presentation is scheduled for 4:30 p.m. PT.
Live webcasts and replays of group presentations will be made available on electroCore’s investor relations website at https://investor.electrocore.com/events-and-presentations.
Investors interested in scheduling a meeting with management at an upcoming event can contact FNK IR at investors@electrocore.com.
electroCore’s participation and schedule is subject to change.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
What investor conferences will electroCore (ECOR) participate in during October 2024?
When is electroCore's (ECOR) group presentation at the LD Micro Main Event XVII?
How can investors access electroCore's (ECOR) presentation webcasts?
Who will electroCore (ECOR) have a fireside chat with at the Maxim Virtual Healthcare Summit?
How can investors schedule meetings with electroCore (ECOR) management at these events?
